文献速递食管与纵隔外科

60岁后起病重症肌无力患者机器人胸腺切除术的结果

Results of Robotic Thymectomy Performed in Myasthenia Gravis Patients Older Than 60 Years at Onset.
PubMed 文献 · Ann Thorac Surg · 2019-03-15

该研究回顾性分析了2003至2017年间在柏林夏里特大学医学院接受机器人胸腺切除术的60岁后起病重症肌无力患者,围手术期并发症率为13.2%,完全稳定缓解率为7.8%,改善率为68.6%,激素用量显著减少,提示该手术安全有效且具有激素节省效应。

要点

  • 60岁后起病MG患者机器人胸腺切除术围手术期并发症率13.2%。
  • 随访中位60个月,完全稳定缓解率7.8%,改善率68.6%。
  • 激素日均剂量显著下降,且未增加硫唑嘌呤用量。

核心结论

  • 机器人胸腺切除术对60岁后起病的重症肌无力患者似乎安全有效,并具有统计学显著的激素节省效应。

主要发现

  • 围手术期并发症率为13.2%,唯一的围手术期死亡原因为主动脉夹层。
  • 中位随访60个月(范围12至263个月),完全稳定缓解率7.8%,改善率68.6%,总死亡率11.8%。
  • 与术前相比,末次随访时皮质类固醇日均剂量显著降低(17.6 ± 23.6 mg 对 2.6 ± 6.1 mg,p = 0.0001),硫唑嘌呤用量无显著增加(35.9 ± 61.9 mg 对 42.7 ± 59 mg,p = 0.427)。
  • 在49例抗乙酰胆碱受体抗体阳性患者中,10例达到「良好结局」,无合并症(比值比7.307,95%CI 1.188至44.937,p = 0.032)和术前MGFA分级I级(比值比6.696,95%CI 1.259至35.620,p = 0.026)为预测因素。

临床怎么用

  • 对于60岁后起病的重症肌无力患者,机器人胸腺切除术可作为安全有效的治疗选择,有助于减少激素用量。

局限性

  • 回顾性设计,样本量有限,部分患者失访,结论需更大规模前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data are limited on the safety and efficacy of robotic thymectomy in patients with myasthenia gravis (MG) older than 60 years at onset. METHODS: Patients older than 60 years at MG onset who underwent robotic thymectomy in Charite Universitaetsmedizin Berlin between 2003 and 2017 were potentially eligible for inclusion. The main outcomes were perioperative complications and clinical outcome according to the Myasthenia Gravis Foundation of America Post-Intervention Status. RESULTS: Sixty-eight (25 women, 43 men) of 580 patients with MG who underwent robotic thymectomy were eligible for perioperative analyses (median age at MG onset 67 years, range: 61 to 85 years). The perioperative morbidity rate was 13.2%, and the only perioperative death was due to aortic dissection. Fifty-one patients were available for further analysis with a median follow-up time of 60 months (range: 12 to 263 months). The complete stable remission rate was 7.8%, the improvement rate was 68.6%, and the overall mortality rate was 11.8%. Compared with preoperative use, the mean daily dose of corticosteroid agents was significantly reduced at the last follow-up (17.6 ± 23.6 mg versus 2.6 ± 6.1 mg, p = 0.0001) without increased use of azathioprine (35.9 ± 61.9 mg versus 42.7 ± 59 mg, p = 0.427). After excluding 2 patients seronegative for the anti-acetylcholine receptor antibody, 10 of 49 seropositive patients achieved "good outcome" (including four complete stable remissions, three pharmacologic remissions, and three minimal manifestations 0) which was predicted by being free of concomitant disease (odds ratio 7.307, 95% confidence interval: 1.188 to 44.937, p = 0.032) and Myasthenia Gravis Foundation of America classification I before thymectomy (odds ratio 6.696, 95% confidence interval: 1.259 to 35.620, p = 0.026). CONCLUSIONS: Robotic thymectomy seems to be safe and effective in patients with MG older than 60 years at onset with a statistically significant steroid-sparing effect.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Li F, Takahashi R, Bauer G, et al. Results of Robotic Thymectomy Performed in Myasthenia Gravis Patients Older Than 60 Years at Onset. Ann Thorac Surg. 2019. PMID: 30885848. doi:10.1016/j.athoracsur.2019.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。